Mitochondrial dysfunction is being increasingly linked to aging and the pathogenesis of several common diseases associated with aging, including type 2 diabetes mellitus (Krishnan et al., 2007) . Type 2 diabetes is characterized by defective insulin release by pancreatic β cells in response to glucose stimulation and decreased insulin sensitivity of peripheral tissues. Several lines of evidence have implicated mitochondrial dysfunction in type 2 diabetes. In humans with insulin resistance, a reduction in the function of the mitochondrial respiratory chain (also known as the electron transport chain) has been observed in liver and muscle. However, it is not known whether or how this disruption in oxidative phosphorylation contributes to the pathogenesis of type 2 diabetes. Pospisilik et al. (2007) now report in this issue of Cell that a reduction in oxidative phosphorylation in the liver or muscle of mice does not trigger the onset of diabetes but instead has the opposite effect, protecting mice against both diabetes and obesity. Their finding suggests that the changes in respiratory chain function in insulin-resistant humans may be compensatory rather than causative in the pathogenesis of type 2 diabetes.
The pancreatic β cell depends on mitochondrial function to appropriately control the release of insulin in response to variation in blood glucose levels (Maassen et al., 2004) . Patients with mitochondrial disease syndromes caused by certain mutations in mitochondrial DNA (mtDNA) are often diabetic because of impaired insulin secretion and increased β cell death (Maassen et al., 2004) . In addition, the normal aging process in humans is associated with accumulation of somatic mutations in mtDNA and a decline in respiratory chain function (Krishnan et al., 2007) . Somatic mutations in mtDNA undergo mitotic segregation and can clonally expand to very high levels in individual cells, thereby causing a mosaic pattern of respiratory chain deficiency in tissues of older humans (Krishnan et al., 2007) . It is possible that accumulation of somatic mutations in mtDNA may partially explain the age-associated deterioration of β cell function and viability.
Human insulin resistance correlates with reduced respiratory chain function in skeletal muscle, as determined by in vivo studies using magnetic resonance spectroscopy (Lowell and Shulman, 2005) . In addition, analyses of gene expression in skeletal muscle of insulin-resistant patients show decreased expression of PGC-1α, a master regulator of mitochondrial biogenesis, and its downstream target genes (Lowell and Shulman, 2005) . A reasonable interpretation of these studies is that inherited or age-associated acquired dysfunction of the respiratory chain in skeletal muscle may trigger insulin resistance and lead to development of type 2 diabetes. A role for mitochondria in insulin resistance is also supported by the fact that physical exercise induces mitochondrial biogenesis and also increases glucose uptake in skeletal muscle. Yet this hypothesis linking deficiency in the respiratory chain to insulin resistance in peripheral tissues has been questioned for several reasons.
(1) Respiratory chain deficiency in skeletal muscle typically causes a compensatory increase in mitochondrial biogenesis driven by an activation of PGC-1α expression. Therefore, it is not expected that respiratory chain deficiency should be accompanied by a decrease in mitochondrial biogenesis, as observed in skeletal muscle of insulin resistant patients. (2) Mice lacking PGC-1α expression are lean and resistant to diet-induced obesity (Lin et al., 2004) . Unfortunately, these knockout mice are also hyperactive, which complicates the interpretation of this phenotype. (3) A recent characterization of respiratory chain function in patients with type 2 diabetes subjected to glucose/insulin infusions suggests that mitochondrial dysfunction is not an intrinsic defect but rather a consequence of the impaired insulin response (Asmann et al., 2006) . (4) Patients with certain mitochondrial disease syndromes often develop diabetes, as discussed above, but they are typically not insulin resistant despite having respiratory chain deficiency in skeletal muscle and other tissues (Maassen et al., 2004) .
In this issue, Pospisilik et al. (2007) demonstrate that a reduction in mitochondrial oxidative phosphorylation protects mice against obesity and diabetes. This finding suggests that the moderate deficiency in oxidative phosphorylation that is observed in peripheral tissues of insulin-resistant humans is not a causative factor in diabetes but may instead be a compensatory response.
Cell 131, November 2, 2007 ©2007 Elsevier Inc. 449 Pospisilik and colleagues (2007) have tested the hypothesis that respiratory chain dysfunction causes insulin resistance by using the power of mouse genetics to manipulate expression of apoptosis-inducing factor (AIF). AIF is necessary for maintaining the normal function of the respiratory chain, whereas its role in apoptosis has been questioned (Brown et al., 2006) . Tissuespecific disruption of AIF in skeletal muscle or liver reduces the activity of complex I, the first component in the respiratory chain, and results in patterns of gene expression that are strikingly similar to those observed in skeletal muscle from insulin-resistant humans. Surprisingly, animals with muscle-specific AIF deficiency (MAIFKO mice) have increased glucose tolerance and increased insulin sensitivity (Figure 1 ). They also have elevated expression of glucose transporters and display increased glucose uptake in skeletal muscle. The knockout mice have no increase in the production of reactive oxygen species. Similarly, animals with liver-specific AIF deficiency (LAIFKO mice) show increased glucose tolerance. MAIFKO and LAIFKO mice are resistant to the development of obesity and diabetes when fed a high-fat diet (Figure 1) . In other experiments, the authors show that acutely decreasing AIF expression or restoring AIF expression in the liver of LAIFKO mice can induce or reverse, respectively, dysfunction of the respiratory chain and thereby alter glucose homeostasis.
Does this elegant series of experiments exclude a role for mitochondrial dysfunction in causing insulin resistance? Not necessarily, because AIF may have more than one function in mitochondria. Future studies are clearly needed to address the molecular mechanisms by which AIF interacts with the respiratory chain. However, the conclusions of Pospisilik and colleagues (2007) are supported by the finding that deletion of the gene encoding mitochondrial transcription factor A (Tfam) in mouse skeletal muscle causes a global progressive deficiency of the respiratory chain, a lowering of blood glucose levels, and an increase in peripheral glucose uptake (Wredenberg et al., 2006) . Similarly, mtDNA-mutator mice, which exhibit a widespread tissue distribution of respiratory chain deficiency because of accumulation of somatic point mutations in mtDNA, are lean and have lower blood glucose levels than control animals (Trifunovic et al., 2004; N.-G.L., unpublished data) . Intriguingly, the study by Pospisilik et al. (2007) indicates that moderate dysfunction in the respiratory chain may have beneficial metabolic effects. It has previously been reported that activation of the deacetylase SIRT1 by resveratrol leads to deacetylation of PGC-1α, which in turn is activated to increase mitochondrial biogenesis (Lagouge et al., 2006) . Animals treated with resveratrol are protected against diet-induced obesity, which may be explained by enhanced mitochondrial biogenesis (Lagouge et al., 2006) . However, it should be emphasized that resveratrol has pleiotropic pharmacological effects and that other mechanisms, in addition to activation of mitochondrial biogenesis, may be important. Thus, there are published data suggesting that both moderate increases and moderate decreases in respiratory chain function have advantageous effects. It will be interesting to unravel the molecular mechanisms behind this dualism and to determine whether the beneficial effects of a moderate reduction in mitochondrial function prolong life span in mice. Studies using global gene expression and in vivo magnetic resonance spectroscopy suggest that respiratory chain deficiency in the mitochondria of skeletal muscle may cause insulin resistance in humans. Muscle-or liver-specific inactivation of apoptosis-inducing factor (AIF) results in a respiratory chain deficiency that primarily affects complex I. The mutant mice have patterns of gene expression closely resembling those seen in patients with insulin resistance and type 2 diabetes mellitus. Unexpectedly, mice deficient in AIF are leaner than littermate controls and show improved glucose tolerance and increased insulin sensitivity in peripheral tissues. In addition, AIF-deficient mice are resistant to developing obesity and diabetes when fed a high-fat diet. These findings show that reduced respiratory chain function can counteract the development of diabetes and obesity.
The ribosome is often considered a rather monochromatic machine that has persisted more or less unchanged for the past three billion years. That picture has begun to take on color as we see the intricate structure of the ribosomal RNAs with their associated proteins and as we learn of the subtle differences between eubacterial, archaeal, eukaryotic, and organellar ribosomes. New work by Komili et al. (2007) presented in this issue suggests that the ribosome, at least in yeast, has far more versatility than anyone had imagined.
About one hundred million years ago, there occurred duplication of the genome of an S. cerevisiae ancestor (Wolfe and Shields, 1997) . Although most of the duplicate genes were either lost or evolved new functions, fifty-nine pairs of paralogous genes that encode identical or very similar ribosomal proteins were retained. It has been thought that this served to accommodate the yeast cell's extraordinary need for ribosomal proteins (Warner, 1999) . Although this may be part of the reason why so many ribosomal protein paralogs were retained in S. cerevisiae, Komili et al. now provide several lines of evidence to suggest that only rarely are individual members of a paralogous gene pair functionally identical. The authors have built on the observation that in some cases deletion of only one gene of a paralogous pair alters bud site selection in S. cerevisiae (Ni and Snyder, 2001) . Taking advantage of the well-studied localization of ASH1 mRNA to the bud tip (Darzacq et al., 2003) , they examined ASH1 mRNA localization after deletion of many of the paralogous genes encoding proteins of both ribosomal subunits. The authors find clear differences in the localization of ASH1 mRNA, which appear to correlate with bud site selection. These effects are neither dependent on the expression level of the duplicate genes nor are they suppressed by overexpression of the other gene, suggesting that the paralogous proteins are performing different functions.
The authors extended their primary observations by exploiting the tools of systems biology in two powerful ways. First, they compared the transcriptomes of yeast cells in which paralogs of genes encoding ribosomal proteins have been deleted and found substantial differences. Then, they mined a variety of data sets describing the phenotypic effects of paralog deletion, and they report marked variance between paralogs. From these data, the authors infer that the paral-
